文献速递肝病消化道肿瘤与早癌

胆管癌及其亚型遗传景观的GWAS与整合分析

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.
PubMed 文献 · Hepatology · 2026-02-02

该研究对2366例欧洲 ancestry 胆管癌患者和11750例对照进行GWAS,发现1个新全基因组显著变异rs535777(OR=1.44)位于HLA-DRB1/DQA1附近,以及2个与肝外胆管癌相关的变异。分层分析揭示与PSC相关和非PSC相关胆管癌的不同位点,HLA归因发现新氨基酸残基,孟德尔随机化支持12个性状与胆管癌或亚型的推定因果关联。

要点

  • rs535777(OR=1.44)位于HLA-DRB1/DQA1附近,与胆管癌风险相关。
  • 肝外胆管癌相关:rs116224263(OR=0.17)和rs6914950(OR=1.63)。
  • PSC相关胆管癌rs2395184(OR=3.51);非PSC相关rs142674434(OR=2.98)。

核心结论

  • 大规模GWAS发现新的胆管癌易感变异及HLA相关机制,多步骤后GWAS分析有助于理解发病机制并推动风险生物标志物开发。

研究设计与样本

  • 对2366例胆管癌病例和11750例欧洲 ancestry 对照进行GWAS,并开展fine-mapping、功能注释和HLA归因等后GWAS分析。

主要发现

  • 鉴定出1个新的全基因组显著变异rs535777(OR=1.44),位于HLA-DRB1/DQA1附近,与胆管癌相关。
  • 发现2个与肝外胆管癌相关的变异:rs116224263(OR=0.17)位于4p15.1的LINC02506,rs6914950(OR=1.63)位于HLA-DRB1/DQB1附近。
  • 分层分析显示rs2395184(OR=3.51)位于HLA-DRA/DRB5附近,与PSC相关胆管癌相关;rs142674434(OR=2.98)位于7p21.3的THSD7A,与非PSC相关胆管癌相关。
  • HLA归因发现与疾病风险相关的新氨基酸残基。
  • 跨性状分析识别胆管癌与人体测量、血脂、生活方式和医学性状之间的共享遗传信号;孟德尔随机化支持12个性状与胆管癌或其亚型的推定因果关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Cholangiocarcinoma (CCA) is a rare but aggressive malignancy with poorly understood genetic susceptibility. To date, genome-wide association studies (GWAS) investigating germline variants associated with CCA risk remain limited. We aimed to identify genetic risk loci for CCA and its clinical subtypes through comprehensive GWAS and post-GWAS analyses. APPROACH AND RESULTS: We conducted a GWAS of 2366 CCA cases and 11,750 controls of European ancestry. Genome-wide significant loci ( p <5×10 -8 ) were identified and further examined through fine-mapping, functional annotation, and HLA imputation. Subgroup analyses were conducted by CCA subtypes and primary sclerosing cholangitis (PSC) status. Cross-trait linkage disequilibrium score regression and Mendelian randomization were employed to investigate the shared genetic architecture and potential causal relationships with a diverse range of traits. We identified 1 new genome-wide significant variant, rs535777 (OR=1.44), near HLA-DRB1/DQA1 associated with CCA, and 2 variants associated with extrahepatic CCA: rs116224263 (OR=0.17) in LINC02506 at 4p15.1 and rs6914950 (OR=1.63) near HLA-DRB1/DQB1 . Stratified analyses revealed rs2395184 (OR=3.51) near HLA-DRA/DRB5 associated with PSC-related CCA, and rs142674434 (OR=2.98) in THSD7A at 7p21.3 associated with non-PSC-related CCA. HLA imputation uncovered new amino acid residues associated with disease risk. Cross-trait analyses identified shared genetic signals between CCA and anthropometric, lipidemic, lifestyle, and medical traits. Mendelian randomization supported putative causal associations for 12 traits with CCA or its subtypes. CONCLUSIONS: Our large-scale GWAS highlights new genetic variants and HLA-linked mechanisms underlying CCA susceptibility. Integrating multi-step post-GWAS approaches enhances understanding of CCA pathogenesis and may facilitate the development of risk biomarkers for early detection and precision prevention strategies.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Han Y, Byun J, VanLith CJ, et al. Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses. Hepatology. 2026. PMID: 41627892. doi:10.1097/HEP.0000000000001699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。